PT  - JOURNAL ARTICLE
AU  - Zhang, Alice
AU  - carrillo, matthew
AU  - Liu, Ryan
AU  - Ballard, Sarah
AU  - Reedy-Cooper, Alexis
AU  - Zgierska, Aleksandra
TI  - Vending machines for harm reduction and community health: a systematic review
AID  - 10.1370/afm.22.s1.6223
DP  - 2024 Nov 20
TA  - The Annals of Family Medicine
PG  - 6223
VI  - 22
IP  - Supplement 1
4099  - http://www.annfammed.org/content/22/Supplement_1/6223.short
4100  - http://www.annfammed.org/content/22/Supplement_1/6223.full
SO  - Ann Fam Med2024 Nov 20; 22
AB  - Context: In response to the growing overdose epidemic, communities in US and Canada have started using vending machines (VMs) as a low-barrier method to provide harm reduction (HR) items to the community. These VMs are becoming popular and typically dispense naloxone, drug testing strips, and other items for co-occurring conditions.Objective: To summarize and evaluate existing literature on VMs’ ability to deliver HR and other health items.Study Design, Analysis: Systematic literature review. For each eligible article, data was extracted and summarized on study design, goals, VM description, setting, location, target population, sample, results, outcome measures, and limitations.Dataset: Embase, Cochrane, PubMED, and MEDLINE (searched from inception to November 29, 2023); references of eligible articles and prior reviews. HR organizations were also contacted to share relevant articles on HR-based VMs.Population Studied: Individuals with substance use disorder or co-occurring conditions.Intervention: VMs or automated dispensing machines dispensing HR and/or health items.Outcome Measures: Feasibility, acceptability, reach, impact.Results: Of the 43 eligible articles, few were based in North America (n=10). Most VMs served those who injected drugs (n=27) and dispensed syringes (n=21). Other items included HIV self-tests (n=6), condoms (n=6), naloxone (n=2), and nicotine gum (n=1). Feasibility was most commonly evaluated (n=34), with high demand for VM-dispensed items, especially after business hours. Compared to in-person outreach, some VMs were able to provide more syringes and HIV self-tests. VMs were acceptable (n=20), regardless of item dispensed, and reached high-risk populations (n=14). Outcome measures for impact evaluation (n=16) varied on the dispensed item. Articles evaluating syringe-dispensing VMs’ impact (n=7) noted decreased syringe sharing (n=4) and drug use (n=2), while those evaluating naloxone-dispensing VMs (n=2) reported fewer fatal overdoses.Conclusions: VMs providing HR-related items are a promising community-based intervention to reach underserved populations and improve health outcomes. While HR-based VMs have been commonly studied and implemented, VMs could expand into other realms of community health, such as self-sampling kits for detection of cancer or sexually transmitted diseases. Future studies should utilize implementation science frameworks to develop and evaluate the VMs, with an emphasis on health outcomes.